In February of 2020, China reported the general success of numerous clinical trials for treating COVID-19 patients with chloroquine (CQ) and hydroxychloroquine (HCQ). Chinese health officials voted unanimously to institute a chloroquine protocol as the standard of care for COVID-19 patients. That same month, both China and South Korea publicly committed to medicating COVID-19 patients with HCQ and CQ. By that time, many rationale papers (here, here, here, here, here, here, here, here, here, and one by the world’s most published infectious disease expert) had already been published in the medical literature recommending one or both of HCQ and CQ as promising drugs for treating novel or known coronaviruses (generally as well as specifically SARS-CoV-2).
However, it is a curious fact that the Western media found nothing at all interesting worth reporting about any of that through the first 78 days of 2020.The Curious Calm Before the Storm
This is a very good article detailing the successful use of HCQ in China and Korea while at the same time HCQ was being studiously ignored by Western MSM. It was not until DJT promoted HCQ that Western media turned savagely on the treatment as well as on the president. The article is not long but has many links to sources, so it provides a very good picture of what happened. ABN